Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificities

BACKGROUND: The potential use of the broadly neutralizing monoclonal antibodies (bnAbs) towards prophylaxis and treatment to HIV-1 is currently being explored. While a number of promising bnAbs have been discovered and a few of them have progressed towards clinical development, their extent of neutr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mullick, Ranajoy, Sutar, Jyoti, Hingankar, Nitin, Deshpande, Suprit, Thakar, Madhuri, Sahay, Seema, Ringe, Rajesh P., Mukhopadhyay, Sampurna, Patil, Ajit, Bichare, Shubhangi, Murugavel, Kailapuri G., Srikrishnan, Aylur K., Goyal, Rajat, Sok, Devin, Bhattacharya, Jayanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120817/
https://www.ncbi.nlm.nih.gov/pubmed/33990195
http://dx.doi.org/10.1186/s12977-021-00556-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120817/
https://www.ncbi.nlm.nih.gov/pubmed/33990195
http://dx.doi.org/10.1186/s12977-021-00556-2

Ejemplares similares